Li Yu
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
HPV-mediated down-regulation of NOD1 inhibits apoptosis in cervical cancer.
Journal: Infectious agents and cancer
Published: May 19, 2019
Upregulated circ_0005576 facilitates cervical cancer progression via the miR-153/KIF20A axis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 15, 2019
Application of p16/Ki-67 dual-staining cytology in cervical cancers.
Journal: Journal of Cancer
Published: January 02, 2019
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy.
Journal: Oncotarget
Published: November 04, 2015
Microarray analysis revealed markedly differential miRNA expression profiles in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.
Journal: Future oncology (London, England)
Published: February 25, 2014
Diagnostic value of HMGB1 immunostaining on cell blocks from residual liquid-based gynecologic cytology specimens.
Journal: Diagnostic cytopathology
Published: December 16, 2013
Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.
Journal: Biochimica et biophysica acta
Published: July 16, 2012
Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?
Journal: Cellular and molecular life sciences : CMLS
Published: July 11, 2011
Olfactomedin 4 is a marker for progression of cervical neoplasia.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 29, 2011
Toll-like receptors, inflammation and tumor in the human female reproductive tract.
Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: June 17, 2009
Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia.
Journal: Cancer immunology, immunotherapy : CII
Published: March 24, 2009
Toll-like receptors expressed in tumor cells: targets for therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: December 09, 2007
Showing 1-12 of 12
Last Updated: 09/26/2026